UOC
ELV icon

UBS O'Connor’s Elevance Health ELV Stock Holding History

UBS O'Connor’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-123,713
Closed -$23.3M – 367
2017
Q2 		$23.3M Sell
123,713
-8,091
-6% -$1.45M 0.38% 70
2017
Q1 		$21.8M Sell
131,804
-1,943
-1% -$309K 0.37% 66
2016
Q4 		$19.2M Buy
+133,747
New +$17.9M 0.37% 76
2013
Q3 		– Sell
-35,000
Closed -$2.86M – 466
2013
Q2 		$2.86M Buy
+35,000
New +$2.62M 0.05% 290

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

UBS O'Connor's ELV Position: Q3 2017 in Review

UBS O'Connor sold out of Elevance Health (ELV) in Q3 2017, closing a stake of 123,713 shares — an estimated $23.3M sold.

UBS O'Connor first reported a position in ELV in Q2 2013 and held it in 4 quarters. The position peaked at $23.3M in Q2 2017. 845 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • UBS O'Connor reported no remaining Elevance Health position as of Q3 2017 after selling out during the quarter.
  • UBS O'Connor sold 123,713 Elevance Health shares in Q3 2017, an estimated $23.3M.
  • UBS O'Connor first reported a position in Elevance Health in Q2 2013 and held it in 4 quarters.
  • UBS O'Connor's Elevance Health position peaked at $23.3M in Q2 2017.
  • 845 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on UBS O'Connor's 13F filing for Q3 2017, filed 14 Nov 2017.